Literature DB >> 29923275

Exploring barriers and facilitators in the implementation and use of guideline recommendations on antipsychotic drug prescriptions for people with intellectual disability.

Lotte Ramerman1,2, Pieter J Hoekstra2, Gerda de Kuijper1,2.   

Abstract

BACKGROUND: It is unknown why professionals' adherence to guideline recommendations on antipsychotic drug prescription in the intellectual disabilities care is insufficient. This study aimed to explore barriers and facilitators in the implementation and use of these recommendations.
METHODS: In-depth interviews with four intellectual disability physicians, two psychiatrists and five behavioural scientists were used to explore the implementation and use of guideline recommendations.
RESULTS: Barriers in adhering to recommendations were lack of collaboration of different disciplines involved in the treatment of psychiatric and behavioural disorders and lack of enforcement of an appropriate monitoring of side- and treatment effects. When guideline recommendations were translated into organizational policies, clinicians were able to divide responsibilities and tasks, needed to appropriately implement guideline recommendations in daily clinical practice.
CONCLUSIONS: To facilitate the use of guideline recommendations, organizations should translate recommendations into organization-specific policies, involving physicians and behavioural scientists in this process, while simultaneously creating more practical and technological support.
© 2018 John Wiley & Sons Ltd.

Entities:  

Keywords:  adherence; antipsychotic drugs; guideline recommendation; implementation; intellectual disability care

Mesh:

Substances:

Year:  2018        PMID: 29923275     DOI: 10.1111/jar.12461

Source DB:  PubMed          Journal:  J Appl Res Intellect Disabil        ISSN: 1360-2322


  4 in total

1.  Acceptability, equity, and feasibility of using antipsychotics in children and adolescents with autism spectrum disorder: a systematic review.

Authors:  Gian Loreto D'Alò; Franco De Crescenzo; Laura Amato; Fabio Cruciani; Marina Davoli; Francesca Fulceri; Silvia Minozzi; Zuzana Mitrova; Gian Paolo Morgano; Franco Nardocci; Rosella Saulle; Holger Jens Schünemann; Maria Luisa Scattoni
Journal:  BMC Psychiatry       Date:  2020-11-25       Impact factor: 3.630

2.  Determinants of successful guideline implementation: a national cross-sectional survey.

Authors:  Ying-Hui Jin; Li-Ming Tan; Khalid S Khan; Tong Deng; Chao Huang; Fei Han; Jing Zhang; Qiao Huang; Di Huang; Dan-Qi Wang; Yu Wang; Xian-Tao Zeng; Qiang Wang; Xing-Huan Wang
Journal:  BMC Med Inform Decis Mak       Date:  2021-01-14       Impact factor: 2.796

3.  Monitoring of Adverse Drug Reaction-Related Parameters in Children and Adolescents Treated With Antipsychotic Drugs in Psychiatric Outpatient Clinics.

Authors:  Lenneke Minjon; Ivona Brozina; Toine C G Egberts; Eibert R Heerdink; Els van den Ban
Journal:  Front Psychiatry       Date:  2021-02-25       Impact factor: 4.157

4.  Management of psychotropic medications in adults with intellectual disability: a scoping review.

Authors:  Ashley Costello; Eithne Hudson; Susan Morrissey; Drona Sharma; Dervla Kelly; Owen Doody
Journal:  Ann Med       Date:  2022-12       Impact factor: 5.348

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.